Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Christine Dora told the Inquiry the report prepared following the Scottish Executive investigation was largely finalised by this date.
Published on:
31 July, 2024
Christine Dora felt that no compensation should be awarded unless harm had been done.
Published on:
31 July, 2024
Christine Dora sought advice from Dr Keel regarding the submission by SNBTS and a number of clinical matters.
Published on:
31 July, 2024
In her written statement, Lynda Towers explained that she was a senior solicitor advising the Scottish Executive during this period.
Published on:
31 July, 2024
Health Department officials met to discuss the way forward with the enquiries into the events surrounding the heat treatment of blood products in Scotland between 1985 and 1987.
Published on:
31 July, 2024
Newsletter
Published on:
12 May, 2020
Christine Dora sent a memo to PS/Minister for Health and Community Care noting that the Haemophilia Society had not confined matters to heat treatment between 1985 and 1987 and seeking approval for a revised remit.
Published on:
31 July, 2024
Dr Keel wrote to Scottish Haemophilia Directors informing them that the Haemophilia Society was particularly interested in pursuing with the Scottish Executive inquiry the issue of what patients were told at the time of Hepatitis C testing, including the clinical implications of a positive diagnosis.
Published on:
31 July, 2024
Haemophilia directors attended a meeting along with officials and haemophilia centre directors from across Scotland in order to establish "whether there was a general policy on what patients were told and whether there [was] an assessment of risk and if patients were given a choice."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Dr Henry Watson of Aberdeen Haemophilia Centre that the clinician "would have to make the decision of whether to hand the patient a host of information or outline the benefits/risks of particular products."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Professor Ludlam that DDAVP could have been used from 1979 but that this was a matter of clinical judgement and "patients were desperate at that time to be prescribed concentrate as this allowed them to treat themselves at home."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland, Professor Ludlam sought advice on whether haemophilia directors should be looking back to try and identify what had happened to people whose whereabouts and status were unknown. Lynda Towers referred to the Central Legal Office and said that haemophilia directors should follow their advice on whether any further investigation or tracking down of patients was necessary.
Published on:
31 July, 2024
The Scottish National Blood Transfusion Service sent to the Scottish Executive a paper in response to requests for information from Christine Dora.
Published on:
31 July, 2024
Thea Teale sent an email to Christine Dora expressing concern about what might come out of the papers which Professor Cash had provided and that they "look carefully for any suggestions that the state of knowledge was other than that which the SNBTS have offered."
Published on:
31 July, 2024
Christine Dora sent an email to Dr Keel and Lynda Towers stating that she did not understand half of the papers obtained from Professor Cash and asked for advice in relation to the sequence of events regarding testing as might relate to their investigation.
Published on:
31 July, 2024
Thea Teale wrote to Christine Dora on 30 March, in response to her query about testing, that it was "a balance between sticking to what we were asked to do & anticipating further demands. I am still inclined not to cover testing in the body of the report."
Published on:
31 July, 2024
Christine Dora circulated a draft of the report 'Hepatitis C and heat treatment of blood products for haemophiliacs in the mid 1980s' to officials.
Published on:
31 July, 2024
Dr Keel provided comments for Christine Dora in response to the draft report, recommending that the conclusion should be made "more definite". She reminded Christine Dora that the Department of Health was very nervous about financial help.
Published on:
31 July, 2024
An email chain between Christine Dora and officials in which it is suggested that the investigation report should not provide support for the Haemophilia Society's calls for compensation for those infected with Hepatitis C.
Published on:
31 July, 2024
John Aldridge wrote in an email to Christine Dora that the Minister should be pointed in the direction of not agreeing to compensation or special priority treatment for those infected with Hepatitis C who may have been infected by NHS treatment.
Published on:
31 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2283
Page
2284
Page
2285
Page
2286
Current page
2287
Page
2288
Page
2289
Page
2290
Page
2291
…
Next page
Next
Last page
Last